Navigation Links
2009 Lasker Awards recognize promise of stem cells -- global market could top $700 million
Date:9/14/2009

New Rochelle, NY, September 14, 2009The recipients of The 2009 Lasker Awards, announced today, represent the dramatic advances achieved in biotechnology research that have led to a revolutionary cancer treatment and the tremendous promise of stem cell therapy for regenerative medicine. Such advances portend a potential $700 million global market for new therapies within less than five years, according to Genetic Engineering & Biotechnology News (GEN, www.genengnews.com).

The Albert Lasker Basic Medical Research Award for 2009 recognizes discoveries in the process that instructs specialized adult cells to form stem cells, and will be presented to Sir John Gurdon, DPhil, DSc, FRS, Emeritus Professor and Group Leader, Gurdon Institute of Cancer & Developmental Biology, University of Cambridge, and Shinya Yamanaka, MD, PhD, Institute for Integrated Cell-Material Sciences, Kyoto University.

The 2009 Lasker-DeBakey Clinical Medical Research Award honors outstanding therapeutic research on chronic myeloid leukemia, and will be given to Brian J. Druker, MD, Professor of Medicine and Director of the Leukemia Center, Oregon Health Sciences University, Nicholas B. Lydon, PhD, formerly of Novartis, and Charles L. Sawyers, MD, Head of the Laboratory in Human Oncology and Pathogenesis, Memorial Sloan-Kettering Cancer Center.

Providing insight and expert commentary on the awards in an article appearing today on the GEN website (www.genengnews.com) are prominent scientists Professor Sir Ian Wilmut, editor of the journal Cloning and Stem Cells (www.liebertpub.com/clo), and Graham Parker, PhD, editor of Stem Cells and Development (www.liebertpub.com/scd). Also providing authoritative perspectives are Maria Freire, PhD, president of the Lasker Foundation, Peter C. Johnson, MD, president and CEO of Scintellix and executive vice president and chief medical officer at Entegrion, and Linda Powers, co-founder and managing director of Toucan Capital, which manages a portfolio that includes 16 stem cell or regenerative medicine companies.

"The 2009 Lasker Awards for basic and clinical research underscore the enormous impact that scientific research and translational medicine will have on human health," said John Sterling, Editor in Chief of GEN. "In the areas of embryonic and adult stem cells, this international recognition of the implications for nuclear reprogramming techniques and the ability to produce stem cells capable of regenerating tissues and organs damaged by disease, trauma, or age, will ignite new research ventures and collaborative partnerships and spark investment across the life sciences sector."

"Both embryonic and adult stem cells offer enormous promise for new treatments and cures," said Mary Ann Liebert, president and CEO of Mary Ann Liebert, Inc. "It is urgent that any health care reform policy ensures coverage for stem cell therapies, gene therapies, tissue engineering, and other regenerative therapeutics and technologies," she said.


'/>"/>

Contact: John Sterling
jsterling@genengnews.com
914-740-2196
Mary Ann Liebert, Inc./Genetic Engineering News
Source:Eurekalert

Related biology news :

1. Anthony S. Fauci awarded Lasker Award for Public Service
2. MGH researcher Gary Ruvkun named a co-recipient of the Lasker Award
3. Gladstones Shinya Yamanaka wins Lasker Award
4. The American Society of Plant Biologists announces 2007 awards
5. Singapore National Science and Technology Awards
6. Homeland Security awards 2 grants to Rutgers for nuclear threat detection
7. NIH awards nearly $23M to University of Chicago for translational research
8. NIH awards researcher $1.5 million new innovator grant for fruit-fly studies of prion proteins
9. PETA awards $120,000 to Duluth Foundation for advancing non-animal tests
10. NIH awards UC $9 million grant to improve patient point-of-care technologies
11. NIST announces 56 new awards for innovative technology research and development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/22/2016)... , June 22, 2016  The American College of ... Trade Show Executive Magazine as one of the fastest-growing ... May 25-27 at the Bellagio in Las Vegas ... the highest percentage of growth in each of the following ... exhibiting companies and number of attendees. The 2015 ACMG Annual ...
(Date:6/21/2016)... , June 21, 2016 NuData ... the new role of principal product architect and ... the director of customer development. Both will report ... technical officer. The moves reflect NuData,s strategic growth ... response to high customer demand and customer focus ...
(Date:6/15/2016)... June 15, 2016 Transparency ... titled "Gesture Recognition Market by Application Market - Global Industry Analysis ... 2024". According to the report, the  global gesture recognition ... 2015 and is estimated to grow at a ... by 2024.  Increasing application of gesture ...
Breaking Biology News(10 mins):
(Date:6/24/2016)... DIEGO , June 24, 2016 ... more sensitively detects cancers susceptible to PARP inhibitors ... circulating tumor cells (CTCs). The new test has ... HRD-targeted therapeutics in multiple cancer types. ... targeting DNA damage response pathways, including PARP, ATM, ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... ... the release of its second eBook, “Clinical Trials Patient Recruitment and Retention Tips.” ... and retention in this eBook by providing practical tips, tools, and strategies for ...
(Date:6/23/2016)... June 23, 2016 /PRNewswire/ - FACIT has announced ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" ... commercialization of a portfolio of first-in-class WDR5 inhibitors ... such as WDR5 represent an exciting class of ... precision medicine for cancer patients. Substantial advances have ...
(Date:6/23/2016)... ... 23, 2016 , ... Charm Sciences, Inc. is pleased to ... AOAC Research Institute approval 061601. , “This is another AOAC-RI approval of the ... Vice President of Regulatory and Industrial Affairs. “The Peel Plate methods perform comparably ...
Breaking Biology Technology: